Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot induction therapy with corticosteroids, tacrolimus, and mycophenolate mofetil in anti-ARS antibody syndrome
jRCTs031240581Recruiting
- Sponsor
- Chiba University Hospital
- Start
- Jan 2025
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus, mycophenolate mofetil and corticosteroids in antisynthetase syndrome (ASSD), interstitial lung disease (ILD) and Myositis, sponsored by Chiba University Hospital. Started Jan 2025; status: recruiting.
02
Drugs
tacrolimusmycophenolate mofetilcorticosteroids
03
Conditions
antisynthetase syndrome (ASSD)interstitial lung disease (ILD)Myositis
Beyond the preview
Go deeper on jRCTs031240581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240581.